Rashesh Sanghvi

Nov 1, 2024 | medrxiv.org | Matthew Neville |Andrew Lawson |Rashesh Sanghvi |Federico Abascal

I.M., M.R.S., and P.J.C. are co-founders, shareholders, and consultants for Quotient Therapeutics Ltd. R.E.A. is an employee of Quotient Therapeutics Ltd. M.E.H. is a co-founder of, consultant to and holds shares in Congenica, a genetics diagnostic company. This research is supported by core funding from Wellcome Trust. R.R. is funded by Cancer Research UK (C66259/A27114) and Medical Research Council (MR/W025353/1).